Bloomage BioTechnology is a injectable hyaluronan soft tisse filling gel
Bloomage, founded in January, 2000 and headquartered in Jinan, is a hyaluronic acid R&D manufacturer. The founder is Zhao Yan. Listed on the SSE on November 6, 2019, the company's major shareholders are Huaxi Xinyu Investment Co., Ltd., China Life Chengda (Shanghai) Health Industry Equity Investment Center (LP) and Ningxia Yingrui Wuyuan PE Partnership Enterprise (LP). Rivals that have direct and indirect competition with Bloomage include Well, Boai Nky, Pharm Agra, Mylan, etc.
ResearchConsumer Staples, Technology, Healthcare
WIA2020 | Rising Tech Stars 2020: Global & China's 100
ResearchReal Estate, Consumer Discretionary, Consumer Staples
Tech for Global, Globalization Footprints of the Established and the New
WIM2020: Insights on the Post-pandemic Outlook for the Healthcare Industry
The curtain came down on Dec 10 on the 'Healthtech Industry and COVID-19 Pandemic' Chapter at WIM 2020. Healthtech entrepreneurs and investors gathered to share insights on the outlook for the healthcare industry, covering topics like vaccination, AI healthcare, intelligent hardware, medical appliances and IVD.
Jan 07, 2021 02:10 PM
WIM2020: Uniting the World through Technology and Innovation
On December 9-12, EqualOcean held the World Innovators Meet (WIM) 2020. This year, the event's main topic was 'Technology and Innovation Connect the World.' WIM2020 gathered innovators from Asia, Africa, Europe and North America to share their knowledge and key achievements, promoting the concept of 'Tech for Equal.'
Dec 17, 2020 07:53 PM
EqualOcean Presents Next 50 in Global Tech: Healthcare (WIA2020)
On December 9-12, EqualOcean is holding the World Innovators Meet (WIM) 2020. This year, the event's main topic is 'Technology and Innovation Connect the World.' WIM2020 gathers innovators from Asia, Africa, Europe and the Americas to share their knowledge and key achievements, promoting the concept of 'Tech for Equal.'
Dec 11, 2020 07:35 PM